NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	e70020
Journal	Clinical and translational medicine
Volume	14
Issue number	9
DOIs	https://doi.org/10.1002/ctm2.70020
Publication status	Published - Sept 2024

Humans, Antigens, Neoplasm/immunology, Immunotherapy/methods, Neoplasms/therapy, Membrane Proteins/immunology, Cancer Vaccines/therapeutic use

ID: 61163607